Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Drug Repurposing: A Strategy for Discovering Inhibitors against Emerging Viral Infections
Igor José dos Santos Nascimento, Thiago Mendonça de Aquino, Edeildo Ferreira da Silva‐Júnior
Current Medicinal Chemistry (2020) Vol. 28, Iss. 15, pp. 2887-2942
Closed Access | Times Cited: 32

Showing 1-25 of 32 citing articles:

Application of Computational Biology and Artificial Intelligence in Drug Design
Yue Zhang, Mengqi Luo, Peng Wu, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 21, pp. 13568-13568
Open Access | Times Cited: 63
The New Era of Drug Discovery: The Power of Computer-aided Drug Design (CADD)
Igor José dos Santos Nascimento, Thiago Mendonça de Aquino, Edeildo Ferreira da Silva‐Júnior
Letters in Drug Design & Discovery (2022) Vol. 19, Iss. 11, pp. 951-955
Closed Access | Times Cited: 52
Diarylureas: Repositioning from Antitumor to Antimicrobials or Multi-Target Agents against New Pandemics
Alessia Catalano, Domenico Iacopetta, Michele Pellegrino, et al.
Antibiotics (2021) Vol. 10, Iss. 1, pp. 92-92
Open Access | Times Cited: 43
Updates on Drug Designing Approach Through Computational Strategies: a Review
Iqbal Azad, Tahmeena Khan, Naseem Ahmad, et al.
Future Science OA (2023) Vol. 9, Iss. 5
Open Access | Times Cited: 17
Repurposed drugs in combinations exert additive anti-chikungunya virus activity: an in-vitro study
Kusuma Sai Davuluri, Rajnandini Ghanghav, Gunwant Ahire, et al.
Virology Journal (2024) Vol. 21, Iss. 1
Open Access | Times Cited: 4
Insights on Dengue and Zika NS5 RNA-dependent RNA polymerase (RdRp) inhibitors
Igor José dos Santos Nascimento, Paulo Fernando da Silva Santos-Júnior, Thiago Mendonça de Aquino, et al.
European Journal of Medicinal Chemistry (2021) Vol. 224, pp. 113698-113698
Closed Access | Times Cited: 29
Emerging drug design strategies in anti-influenza drug discovery
Chuanfeng Liu, Lide Hu, Guanyu Dong, et al.
Acta Pharmaceutica Sinica B (2023) Vol. 13, Iss. 12, pp. 4715-4732
Open Access | Times Cited: 10
Two-way pharmacodynamic modeling of drug combinations and its application to pairs of repurposed Ebola and SARS-CoV-2 agents
Shuang Xu, Shadisadat Esmaeili, E. Fabián Cardozo-Ojeda, et al.
Antimicrobial Agents and Chemotherapy (2024) Vol. 68, Iss. 4
Open Access | Times Cited: 3
Advances in Computational Methods to Discover New NS2B-NS3 Inhibitors Useful Against Dengue and Zika Viruses
Igor José dos Santos Nascimento, Érica Erlanny da Silva Rodrigues, Manuele Figueiredo da Silva, et al.
Current Topics in Medicinal Chemistry (2022) Vol. 22, Iss. 29, pp. 2435-2462
Closed Access | Times Cited: 17
Repurposing FDA-approved Drugs Targeting SARS-CoV2 3CLpro: A Study by Applying Virtual Screening, Molecular Dynamics, MM-PBSA Calculations and Covalent Docking
Igor José dos Santos Nascimento, Thiago Mendonça de Aquino, Edeildo Ferreira da Silva‐Júnior
Letters in Drug Design & Discovery (2022) Vol. 19, Iss. 7, pp. 637-653
Closed Access | Times Cited: 16
Computer-Aided Drug Design of Novel Derivatives of 2-Amino-7,9-dihydro-8H-purin-8-one as Potent Pan-Janus JAK3 Inhibitors
Abdelmoujoud Faris, Ibrahim M. Ibrahim, Omkulthom Al Kamaly, et al.
Molecules (2023) Vol. 28, Iss. 15, pp. 5914-5914
Open Access | Times Cited: 8
Antiviral Potential of Azathioprine and Its Derivative 6- Mercaptopurine: A Narrative Literature Review
C. Ríos–Usuga, Marlén Martínez‐Gutierrez, Julián Ruíz-Sáenz
Pharmaceuticals (2024) Vol. 17, Iss. 2, pp. 174-174
Open Access | Times Cited: 2
Computer-Aided Drug Design of Anti-inflammatory Agents Targeting Microsomal Prostaglandin E2Synthase-1 (mPGES-1)
Igor José dos Santos Nascimento, Thiago Mendonça de Aquino, Edeildo Ferreira da Silva‐Júnior
Current Medicinal Chemistry (2022) Vol. 29, Iss. 33, pp. 5397-5419
Closed Access | Times Cited: 14
Molecular Modeling Targeting Transmembrane Serine Protease 2 (TMPRSS2) as an Alternative Drug Target Against Coronaviruses
Igor José dos Santos Nascimento, Edeildo Ferreira da Silva‐Júnior, Thiago Mendonça de Aquino
Current Drug Targets (2021) Vol. 23, Iss. 3, pp. 240-259
Closed Access | Times Cited: 15
Antiviral effects of the fused tricyclic derivatives of indoline and imidazolidinone on ZIKV infection and RdRp activities of ZIKV and DENV
Guangfeng Zhou, Feng Li, Jian-Xia Xue, et al.
Virus Research (2023) Vol. 326, pp. 199062-199062
Open Access | Times Cited: 5
Molecular Dynamics Simulations in Drug Discovery
Igor José dos Santos Nascimento, Ricardo Olímpio de Moura
Mini-Reviews in Medicinal Chemistry (2024) Vol. 24, Iss. 11, pp. 1061-1062
Closed Access | Times Cited: 1
Rapid electrochemical recognition of trimethoprim in human urine samples using new modified electrodes (CPE/Ag/Au NPs) analysing tunable electrode properties: experimental and theoretical studies
Eduardo Daniel Tecuapa-Flores, José Alberto Hernández, Pedro Roquero, et al.
The Analyst (2021) Vol. 146, Iss. 24, pp. 7653-7669
Closed Access | Times Cited: 11
Discovery of ZFD-10 of a pyridazino[4,5-b]indol-4(5H)-one derivative as an anti-ZIKV agent and a ZIKV NS5 RdRp inhibitor
Guangfeng Zhou, Weiyi Qian, Feng Li, et al.
Antiviral Research (2023) Vol. 214, pp. 105607-105607
Closed Access | Times Cited: 4
Yin-yang in drug discovery: rethinking de novo design and development of predictive models
Ana L. Chávez‐Hernández, Edgar López‐López, José L. Medina‐Franco
Frontiers in Drug Discovery (2023) Vol. 3
Open Access | Times Cited: 4
Targeting SmCB1: Perspectives and Insights to Design Antischistosomal Drugs
Igor José dos Santos Nascimento, Sonaly Lima Albino, Karla Joane da Silva Menezes, et al.
Current Medicinal Chemistry (2023) Vol. 31, Iss. 16, pp. 2264-2284
Closed Access | Times Cited: 4
Discovery of dehydroandrographolide derivatives with C19 hindered ether as potent anti-ZIKV agents with inhibitory activities to MTase of ZIKV NS5
Weiyi Qian, Guangfeng Zhou, Xintong Ge, et al.
European Journal of Medicinal Chemistry (2022) Vol. 243, pp. 114710-114710
Closed Access | Times Cited: 6
Exploring Scoring Function Space: Developing Computational Models for Drug Discovery
Gabriela Bitencourt‐Ferreira, Marcos A. Villarreal, Rodrigo Quiroga, et al.
Current Medicinal Chemistry (2023) Vol. 31, Iss. 17, pp. 2361-2377
Closed Access | Times Cited: 2
Deciphering the Underlying Mechanisms of Sanleng-Ezhu for the Treatment of Idiopathic Pulmonary Fibrosis Based on Network Pharmacology and Single-cell RNA Sequencing Data
Xianqiang Zhou, Fang Tan, Suxian Zhang, et al.
Current Computer - Aided Drug Design (2023) Vol. 20, Iss. 6, pp. 888-910
Open Access | Times Cited: 2
The Power of Molecular Dynamics Simulations and Their Applications to Discover Cysteine Protease Inhibitors
Igor José dos Santos Nascimento, Joilly Nilce Santana Gomes, Jéssika de Oliveira Viana, et al.
Mini-Reviews in Medicinal Chemistry (2023) Vol. 24, Iss. 11, pp. 1125-1146
Open Access | Times Cited: 2
Would the Development of a Multitarget Inhibitor of 3CLpro and TMPRSS2 be Promising in the Fight Against SARS-CoV-2?
Igor José dos Santos Nascimento, Ricardo Olímpio de Moura
Medicinal Chemistry (2022) Vol. 19, Iss. 5, pp. 405-412
Closed Access | Times Cited: 4
Page 1 - Next Page

Scroll to top